Boston Neuro Research is dedicated to understanding the various causes and developing effective treatments for memory loss, a condition that can arise from multiple factors including aging, neurological disorders, and psychological conditions.

INCLUSIONS:

Participants eligible for the memory loss study at Boston Neuro Research must meet the following criteria:

1. Diagnosis: Individuals must have a clinical diagnosis of memory impairment.
2. Age: Participants should be aged 40 to 85 years.
3. Health Status: Stable medical conditions unrelated to memory loss that do not interfere with study procedures.
4. Caregiver: A reliable caregiver must be available to assist with participation in the study.
5. Informed Consent: Participants and caregivers must provide informed consent to join the study.

EXCLUSIONS:

Factors that may disqualify individuals from the memory loss study include:

1. Severe Neurological Disorders: Presence of significant neurological disorders such as advanced Alzheimer’s or Parkinson’s disease.
2. Unstable Medical Conditions: Uncontrolled chronic illnesses such as severe cardiovascular disease or diabetes.
3. Recent Participation: Involvement in other clinical trials within the past 30 days.
4. Psychiatric Disorders: Severe psychiatric conditions that could interfere with the study.

MEDICATIONS:

Participants in the memory loss study will be administered specific medications and interventions to target the underlying causes and symptoms. These may include:

1. Cognitive Enhancers: Medications designed to improve cognitive function.
2. Investigational Drugs: New compounds being tested for their effectiveness and safety in treating memory loss.
3. Adjunct Therapies: Additional treatments such as cognitive behavioral therapy, antioxidants, and lifestyle modifications.

This study aims to provide valuable insights and potential treatments for those experiencing memory loss.